Rgenix's Series A Round

Rgenix raised a round of funding on August 18, 2015.

Rgenix is a privately-held cancer therapeutics company focused on the discovery and development of novel cancer drugs that target key pathways in cancer progression. Using a miRNA based target discove…

Articles about Rgenix's Series A Round: